↓ Skip to main content

Dove Medical Press

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

Overview of attention for article published in OncoTargets and therapy, October 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy
1 policy source
patent
1 patent

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
17 Mendeley
Title
ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy
Published in
OncoTargets and therapy, October 2017
DOI 10.2147/ott.s142698
Pubmed ID
Authors

Fangbin Song, Jianbing Zhang, Shanbao Li, Junyi Wu, Tao Jin, Jun Qin, Ye Wang, Min Wang, Junming Xu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 18%
Student > Master 3 18%
Other 2 12%
Lecturer 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 7 41%
Readers by discipline Count As %
Medicine and Dentistry 6 35%
Nursing and Health Professions 1 6%
Computer Science 1 6%
Engineering 1 6%
Unknown 8 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2022.
All research outputs
#5,449,088
of 25,382,440 outputs
Outputs from OncoTargets and therapy
#278
of 3,016 outputs
Outputs of similar age
#88,040
of 331,218 outputs
Outputs of similar age from OncoTargets and therapy
#6
of 77 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,218 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.